Ansamitocin P-3
(Synonyms: 安丝菌素P 3; Antibiotic C 15003P3; Maytansinol isobutyrate) 目录号 : GC11947
A microtubule depolymerizing agent
Cas No.:66547-09-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cell experiment: | MCF-7, EMT-6/AR1, HeLa and MDA-MB-231 cells are seeded in 96 well plates. Subsequently, cells are incubated with vehicle (0.1% DMSO) or different concentrations (1-1000 pM) of Ansamitocin P3 for 48 h in MCF-7 cells and 24 h for EMT-6/AR1, HeLa and MDA-MB-231 cells, respectively. The half maximal inhibitory concentration of cell proliferation (IC50) for Ansamitocin P3 is determined by sulforhodamine B assay. Four independent experiments are carried out in MCF-7 cells and three independent sets of experiments are performed in EMT-6/AR1, HeLa and MDA-MB-231 cells[2]. |
References: [1]. Kiso T, et al. Screening for microtubule-disrupting antifungal agents by using a mitotic-arrest mutant of Aspergillus nidulans and novel action of phenylalanine derivatives accompanying tubulin loss. Antimicrob Agents Chemother. 2004 May;48(5):1739-48 | |
Ansamitocin P-3, a natural product, is maytansinoid which showed potent cytotoxicity against the human solid tumor cell lines A-549 and HT-29 with ED50 of 4 x 10 -7, 4 x 10 – 7 μg/ml, respectively. [1]
Cytotoxic agents remain an important strategy in chemotherapy. In an activity-directed isolation and identification, ansamitocin P-3 was obtained from the active methanol extracts of two mosses.
Furthermore, the compound showed great cytotoxicity against several tumor cells. [1]
Ansamitocin P-3 is a maytansinoid isolated in very low yield from two members of the moss family Thuidiaceae, Claopodium crispifolium (Hook.) Ren. & Card. and Anomodon attenuatus (Hedw.) Hueb. Further biological evaluation of ansainitocin P-3 showed potent cytotoxicity against the human solid tumor cell line systems A-549 lung carcinoma cells, HT-29 colon adenocarcinoma cells and MCF-7 breast adenocarcinoma cells at ED50 of 4 x 10 -7, 4 x 10 - 7, 2 x 10 -6 μg/ml. respectively. [2]
Ansamitocin P-3 exhibited inhibition of cilia regeneration of partially deciliated Tetrahymena. The regeneration of cilia in Tetrahymena was assayed by observing recovery of motility of the deciliated cells which are nonmotile after being deciliated. After 60 min of incubation, more than 95% of partially deciliated Tetrahymena cells in the recovery buffer were fully motile. Ansamitocin P-3 completely inhibited cilia regeneration of Tetrahymena at 1 μM. Moreover, recovery of motility of partially deciliated cells after release from inhibition by 2 μM ansamitocin P-3. [2]
References：
[1]. Suwanborirux, K., et al. "Ansamitocin P-3, a maytansinoid, fromClaopodium crispifolium andAnomodon attenuatus or associated actinomycetes."Experientia 46.1 (1990): 117-120.
[2]. Tanida, Seiichi, Eiji Higashide, and Masahiko Yoneda. "Inhibition of cilia regeneration of Tetrahymena by ansamitocins, new antitumor antibiotics."Antimicrobial agents and chemotherapy 16.1 (1979): 101.
| Cas No. | 66547-09-9 | SDF | |
| 别名 | 安丝菌素P 3; Antibiotic C 15003P3; Maytansinol isobutyrate | ||
| Canonical SMILES | CCCC(O[C@@]([C@]1([C@@](O1)([H])[C@]([C@](O2)([H])C[C@](N=C2O)(O)[C@@](OC)([H])/C([H])=C([H])/C([H])=C(CC3=CC(N4C)=C(Cl)C(OC)=C3)\C)([H])C)C)([H])CC4=O)=O | ||
| 分子式 | C32H43ClN2O9 | 分子量 | 635.14 |
| 溶解度 | ≥ 31.75 mg/mL in DMSO, ≥ 33.73 mg/mL in EtOH with ultrasonic and warming | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.5745 mL | 7.8723 mL | 15.7446 mL |
| 5 mM | 0.3149 mL | 1.5745 mL | 3.1489 mL |
| 10 mM | 0.1574 mL | 0.7872 mL | 1.5745 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。